✦ LIBER ✦

252Valacyclovir compared to acyclovir for cytomegalovirus prophylaxis in allogeneic stem cell transplants recipients

✍ Scribed by A.S. Artz; N. Dieterle; J. Gelms; S. Parsad; R. Larson; W. Stock; C. Daugherty; T. Zimmerman; O. Odenike; S. Smith; K. Van Besien

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative randomised study of valacy

✍ I. D. Pavlopoulou; V. Ph. Syriopoulou; H. Chelioti; G. L. Daikos; D. Stamatiades 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Vanganciclovir prophylaxis for the preve

✍ M. Magalhaes-Silverman; T. Carter; R. Hohl; H. Shamsuddin; R. Gingrich 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Preemptive Therapy for Cytomegalovirus D

✍ F. de la Cruz-Vicente; P. Cerezuela Martinez; E. Gil-Espárraga; C. Martin Aguile 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Assessment of cellular immunity to human

✍ Simon F Lacey; Don J Diamond; John A Zaia 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 337 KB

Evaluation of diagnostic methods for the

✍ Wolfgang Preiser; Susanne Bräuninger; Rainer Schwerdtfeger; Ursula Ayliffe; Jere 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Maribavir prophylaxis for prevention of

✍ Francisco M Marty; Per Ljungman; Genovefa A Papanicolaou; Drew J Winston; Roy F 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 259 KB